Cross-Sector entity
Jitin Prasada is most often covered alongside Piyush Goyal, which appears in 3 of these 3 stories. Across a 57-day span, the pace is roughly 0.4 stories per week. The busiest single day carried 2. The clearest coverage concentration is economy: 1 of 3 stories, with the rest divided among 2 other categories.
3 verified stories tracked
Last mentioned: Sep 7, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Jitin Prasada is most often covered alongside Piyush Goyal, which appears in 3 of these 3 stories. Across a 57-day span, the pace is roughly 0.4 stories per week. The busiest single day carried 2. The clearest coverage concentration is economy: 1 of 3 stories, with the rest divided among 2 other categories. Jitin Prasada appears in 3 tracked Cross-Sector stories published from July 13, 2026 through September 7, 2026. Each carries 2.3 original sources on average.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Jitin Prasada. Shared-story counts are live from our verified record — not editorial picks.
India's top commerce officials used the Bharat Health Global Expo 2026 to signal a policy pivot from affordable generics toward biosimilars and AI-enabled innovation. For healthcare leaders, the remarks point to evolving supply dynamics, potential new treatment options, and a stronger Indian role in global health resilience.
Union Commerce Minister Piyush Goyal urged India's pharma sector to move beyond generics into biosimilars, biotech, and patented R&D. Biotech and pharma executives should watch for regulatory changes around clinical trials, IP, and convergence with developed markets.
Source: asiabulletin.com · (in)
India’s Commerce Minister visits Spain, Belgium, and Finland (July 13-17) with a business delegation to accelerate the India-EU Free Trade Agreement. Key meetings with Spanish ministers and EU officials, plus CEO talks with Thales and Silox, could unlock cross-border investment in renewables, digital tech, and advanced manufacturing. Markets will watch for concrete FDI announcements and FTA progress that may boost export-oriented sectors.
Source: ianslive.in · theshillongtimes.com
